Brimonidine/Timolol Sandoz 2 mg/ml - 5 mg/ml eye drops sol. dropper cont. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

brimonidine/timolol sandoz 2 mg/ml - 5 mg/ml eye drops sol. dropper cont.

sandoz sa-nv - brimonidine tartrate 2 mg/ml - eq. brimonidine 1,3 mg/ml; timolol maleate 6,8 mg/ml - eq. timolol 5 mg/ml - eye drops, solution - 2 mg/ml - 5 mg/ml - brimonidine tartrate 2 mg/ml; timolol maleate 6.8 mg/ml - timolol

SIMBRINZA 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle Australia - English - Department of Health (Therapeutic Goods Administration)

simbrinza 1%/0.2% brinzolamide 1% and brimonidine tartrate 0.2% eye drops suspension bottle

novartis pharmaceuticals australia pty ltd - brimonidine tartrate, quantity: 2 mg/ml; brinzolamide, quantity: 10 mg/ml - eye drops, suspension - excipient ingredients: propylene glycol; boric acid; mannitol; tyloxapol; sodium chloride; sodium hydroxide; purified water; carbomer 974p; hydrochloric acid; benzalkonium chloride - decrease of elevated intraocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction

ENIDIN brimonidine tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

enidin brimonidine tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: polyvinyl alcohol; benzalkonium chloride; citric acid; hydrochloric acid; sodium citrate dihydrate; sodium chloride; sodium hydroxide; purified water - indications:enidin eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: enidin eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension.enidin eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

BRIMONIDINE TARTRATE solution/ drops United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution/ drops

physicians total care, inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate 2 mg in 1 ml - brimonidine tartrate ophthalmic solution 0.2% is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. the lop lowering efficacy of brimonidine tartrate ophthalmic solution 0.2% diminishes over time in some patients. this loss of effect appears with a variable time of onset in each patient and should be closely monitored. brimonidine tartrate ophthalmic solution 0.2% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

Brimonidine Tartrate 2mg/ml eye drops solution Malta - English - Medicines Authority

brimonidine tartrate 2mg/ml eye drops solution

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - brimonidine tartrate - eye drops, solution - brimonidine tartrate 2 mg/ml - ophthalmologicals

Combigan New Zealand - English - Medsafe (Medicines Safety Authority)

combigan

abbvie limited - brimonidine tartrate 2 mg/ml;  ; timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml;   - eye drops, solution - 2mg/ml, 5mg/ml - active: brimonidine tartrate 2 mg/ml   timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml   excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate purified water sodium hydroxide - combigan® eye drops are indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension not adequately responding to monotherapy.

Brimonidine-AFT New Zealand - English - Medsafe (Medicines Safety Authority)

brimonidine-aft

aft pharmaceuticals ltd - brimonidine tartrate 2 mg/ml;   - eye drops, solution - 0.2% w/v - active: brimonidine tartrate 2 mg/ml   excipient: benzalkonium chloride citric acid polyvinyl alcohol purified water sodium chloride sodium citrate dihydrate sodium hydroxide

ALPHAGAN Brimonidone tartrate 2mg/mL eye drop bottle Australia - English - Department of Health (Therapeutic Goods Administration)

alphagan brimonidone tartrate 2mg/ml eye drop bottle

abbvie pty ltd - brimonidine tartrate, quantity: 2 mg/ml - eye drops, solution - excipient ingredients: sodium hydroxide; purified water; sodium chloride; polyvinyl alcohol; citric acid; benzalkonium chloride; hydrochloric acid; sodium citrate dihydrate - indications: alphagan eye drops are effective as monotherapy for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension in whom (beta symbol)-blockers are not tolerated or are contraindicated. indications as at 7 december 1999: alphagan eye drops are effective in lowering elevated intraocular pressure in patients with chronic open angle glaucoma or ocular hypertension. alphagan eye drops can be used in the treatment of glaucoma either as monotherapy or in combination with topical beta-blockers.

BRIMONIDINE TARTRATE solution United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution

physicians total care, inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate 1.5 mg in 1 ml - brimonidine tartrate ophthalmic solution, 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution, 0.15% is contraindicated in patients with hypersensitivity to brimonidine tartrate or any component of this medication. it is also contraindicated in patients receiving monoamine oxidase (mao) inhibitor therapy.

BRIMONIDINE TARTRATE solution United States - English - NLM (National Library of Medicine)

brimonidine tartrate solution

sandoz inc - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brimonidine tartrate 1.5 mg in 1 ml - brimonidine tartrate ophthalmic solution, 0.15% is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. brimonidine tartrate ophthalmic solution, 0.15% is contraindicated in patients with hypersensitivity to any component of this product. reproductive studies performed in rats and rabbits with oral doses of 0.66 mg base/kg revealed no evidence of harm to the fetus due to brimonidine tartrate ophthalmic solution, 0.15%. dosing at this level produced an exposure in rats and rabbits that is 80 and 40 times higher than the exposure seen in humans, respectively. there are no adequate and well-controlled studies in pregnant women. in animal studies, brimonidine crossed the placenta and entered into the fetal circulation to a limited extent. brimonidine tartrate ophthalmic solution, 0.15% should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. it is not known whether this drug is excreted in h